MTNB - Matinas BioPharma Holdings, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q2 FY2011 Aug 10, 2011 10-Q ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	N/M	—	—	—	N/M	—	—	—	N/M	—	—	—	—	—	—	—	—	—	-0.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	—	N/M	N/M	100.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	100.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	—	—	—	—	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	9.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	84.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	52.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-5050.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1000.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-37.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-2733.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-6000.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	-50.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-16.0% Weak ↓ Weak Declining Year-over-year change in net income	77.3% Excellent ↑ Excellent Improving Year-over-year change in net income	64.2% Excellent ↑ Excellent Improving Year-over-year change in net income	8.3% Fair ↓ Fair Declining Year-over-year change in net income	71.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-58.7% Weak ↓ Weak Declining Year-over-year change in net income	29.4% Excellent ↑ Excellent Improving Year-over-year change in net income	5.6% Fair ↑ Fair Improving Year-over-year change in net income	-5.6% Weak ↑ Weak Improving Year-over-year change in net income	-46.2% Weak ↓ Weak Declining Year-over-year change in net income	-10.9% Weak ↓ Weak Declining Year-over-year change in net income	-2.3% Weak ↓ Weak Declining Year-over-year change in net income	7.8% Fair ↓ Fair Declining Year-over-year change in net income	45.8% Excellent ↑ Excellent Improving Year-over-year change in net income	20.1% Good ↑ Good Improving Year-over-year change in net income	-23.6% Weak ↓ Weak Declining Year-over-year change in net income	-20.6% Weak ↓ Weak Declining Year-over-year change in net income	-5.6% Weak ↓ Weak Declining Year-over-year change in net income	-25.5% Weak ↓ Weak Declining Year-over-year change in net income	14.6% Fair ↑ Fair Improving Year-over-year change in net income	1.8% Caution ↑ Caution Improving Year-over-year change in net income	-13.8% Weak ↑ Weak Improving Year-over-year change in net income	-23.7% Weak ↑ Weak Improving Year-over-year change in net income	-67.7% Weak ↓ Weak Declining Year-over-year change in net income	-24.6% Weak ↑ Weak Improving Year-over-year change in net income	-53.7% Weak ↓ Weak Declining Year-over-year change in net income	-50.0% Weak ↓ Weak Declining Year-over-year change in net income	1.9% Caution ↓ Caution Declining Year-over-year change in net income	1.4% Caution ↓ Caution Declining Year-over-year change in net income	0.0% Caution ↓ Caution Declining Year-over-year change in net income	13.5% Fair ↑ Fair Improving Year-over-year change in net income	14.0% Fair ↑ Fair Improving Year-over-year change in net income	8.6% Fair ↑ Fair Improving Year-over-year change in net income	-91.8% Weak ↑ Weak Improving Year-over-year change in net income	-84.7% Weak ↓ Weak Declining Year-over-year change in net income	-144.3% Weak ↓ Weak Declining Year-over-year change in net income	-100.3% Weak ↓ Weak Declining Year-over-year change in net income	5.7% Fair ↓ Fair Declining Year-over-year change in net income	14.7% Fair ↓ Fair Declining Year-over-year change in net income	32.5% Excellent ↑ Excellent Improving Year-over-year change in net income	12.7% Fair ↑ Fair Improving Year-over-year change in net income	—	17.5% Good ↓ Good Declining Year-over-year change in net income	0.9% Caution ↑ Caution Improving Year-over-year change in net income	56.9% Excellent ↑ Excellent Improving Year-over-year change in net income	—	-79.3% Weak ↑ Weak Improving Year-over-year change in net income	-606.6% Weak Weak Year-over-year change in net income	-5223.8% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	36.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-1386.5% Weak Weak Year-over-year change in free cash flow	—	—	—	-41.1% Weak Weak Year-over-year change in free cash flow	—	—	—	23.1% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	127.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	3.6% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	11.6% Good Good Compound annual revenue growth over 3 years	28.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	105.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	88.3% Excellent → Excellent Stable Compound annual revenue growth over 5 years	88.3% Excellent Excellent Compound annual revenue growth over 5 years	88.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	9.9% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q2 FY2011 Aug 10, 2011 10-Q ↗
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-341.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2949%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-372.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-408.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.42x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.12x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q2 FY2011 Aug 10, 2011 10-Q ↗
Return on Invested Capital (%)	-50.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-88.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-117.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-33.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-67.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-30.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-21.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-98.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-63.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-524%)	-39.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-364%)	-23.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-68.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-556%)	-26.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-276%)	-111.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-841%)	-27.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	-29.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-300%)	-40.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-367%)	-27.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-284%)	-26.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-274%)	-21.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	-16.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	-9.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-14.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-13.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-12.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-12.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-11.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-7.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	-7.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-8.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-7.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	-6.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-16.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-212%)	-11.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-8.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-9.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-22.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	-28.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-290%)	-27.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	-48.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-425%)	-34.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-326%)	-26.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-277%)	-26.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-274%)	-23.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-26.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-276%)	-21.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-54.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-461%)	-53.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-455%)	-33.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-320%)	-31.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-306%)	-27.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-286%)	-40.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-368%)	—	-55.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-467%)	-37.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-350%)	-69.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-562%)	-17.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	—	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q2 FY2011 Aug 10, 2011 10-Q ↗
Net Debt (USD)	$-2.40M	$-4.00M	$-5.43M	$-6.53M	$-6.92M	$-7.28M	$-10.29M	$-4.22M	$-1.07M	$-4.79M	$-6.41M	$-9.74M	$-5.74M	$-6.83M	$-11.18M	$-10.40M	$-19.33M	$-21.03M	$-24.92M	$-30.35M	$-23.38M	$-12.43M	$-7.05M	$-14.90M	$-10.08M	$-22.17M	$-32.66M	$-36.83M	$-39.41M	$-12.45M	$-6.63M	$-8.90M	$-4.26M	$-7.31M	$-9.00M	$-11.27M	$-15.83M	$-4.11M	$-6.22M	$-578.31K	$-1.67M	$-3.23M	$-4.36M	$-6.61M	$-4.62M	$-2.59M	$-5.01M	$-6.65M	$-8.56M	$-10.84M	$-12.57M	$-461.51K	$-424.36K	$-424.36K	$0.00

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q2 FY2011 Aug 10, 2011 10-Q ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$0.01	—	$0.00	$0.00	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.30	$-0.26	$-0.40	$-1.03	$-0.33	$-1.68	$-0.85	$-0.02	$-0.03	$-1.22	$-0.03	$-0.03	$-0.03	$-0.02	$-0.03	$-0.03	$-0.03	$-0.03	—	$-0.02	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.25	—	$-0.27	$-0.40	$-0.39	—	—	—	$-0.03	—	—	—	$-0.02	—	—	—	$-0.02	—	—	$-0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.47	$0.75	$1.09	$1.51	$1.23	$1.49	$3.10	$0.08	$0.07	$4.43	$0.11	$0.13	$0.15	$0.17	$0.18	$0.20	$0.22	$0.24	$0.27	$0.31	$0.33	$0.32	$0.34	$0.37	$0.39	$0.20	$0.23	$42.73	$0.30	$0.14	$0.11	$0.13	$0.09	$0.11	$0.14	$0.17	$0.21	$0.12	$0.15	$0.05	$0.07	—	$0.12	$0.15	$0.14	$0.07	$0.15	$0.20	$0.27	$0.33	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.12	$0.40	$0.71	$1.06	$0.79	$1.05	$2.25	$0.06	$0.05	$3.43	$0.09	$0.11	$0.13	$0.15	$0.16	$0.18	$0.20	$0.22	$0.26	$0.31	$0.32	$0.30	$0.34	$0.36	$0.39	$0.19	$0.23	$41.31	$0.29	$0.13	$0.09	$0.12	$0.08	$0.10	$0.12	$0.15	$0.19	$0.10	$0.13	$0.03	$0.05	—	$0.10	$0.13	$0.11	$0.07	$0.15	$0.20	$0.27	$0.33	—	—	—	—	—
Basic Weighted Avg Shares (shares)	6.41M	—	5.44M	5.09M	5.09M	—	5.04M	249.35M	217.36M	—	217.26M	217.26M	217.26M	—	216.86M	216.86M	216.64M	—	—	205.22M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q2 FY2011 Aug 10, 2011 10-Q ↗
Working Capital (USD)	$689.00K	$2.61M	$4.16M	$5.48M	$5.29M	$5.36M	$9.62M	$12.89M	$8.29M	$12.92M	$16.76M	$21.41M	$26.31M	$30.25M	$32.20M	$36.54M	$41.35M	$46.65M	$52.38M	—	$60.91M	$57.99M	$62.36M	$66.80M	$71.45M	$26.83M	$31.63M	$33.96M	$36.79M	$10.25M	$4.89M	$7.85M	$3.86M	$6.19M	$8.29M	$10.40M	$14.84M	$3.12M	$5.17M	$-568.00K	$591.56K	—	$4.01M	$5.74M	$3.53M	$1.69M	$4.09M	$5.81M	$7.97M	$10.07M	—	—	—	—	—
Total Equity (USD)	$3.02M	$4.83M	$6.46M	$7.67M	$6.27M	$7.59M	$15.78M	$19.10M	$14.56M	$19.25M	$23.15M	$27.85M	$32.62M	$36.64M	$38.62M	$42.85M	$47.68M	$52.49M	$58.25M	$62.90M	$66.56M	$63.73M	$68.21M	$72.82M	$77.60M	$33.05M	$37.98M	$40.42M	$43.01M	$16.14M	$10.30M	$12.53M	$8.43M	$10.68M	$12.78M	$15.21M	$18.86M	$7.15M	$8.72M	$3.00M	$4.22M	$6.07M	$6.96M	$8.63M	$6.39M	$2.23M	$4.75M	$6.46M	$8.61M	$10.47M	—	—	—	$-116.59K	—

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q2 FY2014 Jun 30, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q3 FY2013 Sep 30, 2013 10-Q ↗	Q2 FY2013 Jun 30, 2013 10-Q ↗	Q1 FY2013 Mar 31, 2013 10-Q ↗	Q4 FY2012 Dec 31, 2012 10-K ↗	Q2 FY2011 Aug 10, 2011 10-Q ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	$0.00	—	—	$1.10M	$1.06M	$1.06M	$1.06M	—	$-333.00	—	$0.00	$33.33K	$62.50K	$95.83K	—	—	$0.00	—	$89.81K	—	$0.00	$0.00	$89.81K	$29.94K	$44.91K	$44.91K	$44.91K	$14.97K	—	$0.00	$0.00	$0.00	$0.00	$59.86K	—	—	$0.00	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	$3.00K	$-1.00K	$12.00K	$18.00K	$90.00K	—	—	$94.00K	$97.00K	—	—	$93.00K	$92.98K	$89.22K	$85.80K	$68.97K	$64.58K	$62.00K	$58.55K	$58.65K	$57.81K	$57.80K	$57.80K	$57.62K	$57.05K	—	—	$47.87K	$61.74K	—	—	$47.14K	$44.38K	—	$12.00K	$11.99K	$12.68K	—	—	$12.89K	$10.84K	—	$9.58K	$10.86K	$-9.91K	$31.56K	—	$10.58K	$469.00	$-2.92K	$3.58K	$0.00	—	—
Net Income, GAAP (USD)	$-1.92M	$-1.91M	$-1.53M	$-5.25M	$-1.66M	$-8.43M	$-4.28M	$-5.72M	$-5.82M	$-5.31M	$-6.05M	$-6.06M	$-5.51M	$-3.63M	$-5.46M	$-5.92M	$-5.98M	$-6.70M	$-6.84M	$-4.79M	$-4.96M	$-6.34M	$-5.45M	$-5.61M	$-5.05M	$-5.57M	$-4.40M	$-3.34M	$-4.05M	$-3.63M	$-2.94M	$-3.41M	$-4.11M	$-3.63M	$-3.39M	$-3.97M	$-4.50M	$-1.89M	$-1.84M	$-1.62M	$-2.24M	$-2.01M	$-2.15M	$-2.40M	$-2.57M	—	$-2.61M	$-2.43M	$-5.97M	$-1.80M	$-1.46M	$-343.31K	$-112.13K	—	—
Operating Cash Flow (USD)	$-1.60M	$-1.51M	$-1.47M	$-2.02M	$-2.01M	$-3.51M	—	—	$-5.77M	$-4.58M	—	—	$-4.09M	$-4.30M	—	—	$-4.76M	$-3.96M	—	$-864.65K	$-4.65M	$-4.31M	—	—	$-4.66M	$-4.90M	—	—	$-3.02M	$-2.62M	—	—	$-2.81M	$-1.92M	—	—	—	$-2.12M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Matinas BioPharma Holdings, Inc.

Analytical Summary

55-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MTNB with peers